Xenon Pharmaceuticals Inc. (XENE) Insider Trading
Over the last 3 months, XENE insiders made 0 open-market buys and 15 sales, a net sale of -$17.8M (SEC Form 4). Over the last 6 months, 217 institutions increased and 135 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
15
Net (3m)
-$17.8M
Insider trades by month Buys Sells
Jan
Jun
Oct
Dec
Jan
Mar
Context3-month price +24.2%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 3, 2026 | GANNON STEVENdirector | Grant | 1,593 | — |
| Jun 3, 2026 | GAROFALO ELIZABETH A.director | Grant | 10,507 | $53.46 |
| Jun 3, 2026 | Svoronos Dawndirector | Tax | 1,416 | $53.41 |
| Jun 3, 2026 | Cannon Gilliandirector | Grant | 1,593 | — |
| Jun 3, 2026 | Machado Patrickdirector | Grant | 1,593 | — |
| Jun 3, 2026 | Svoronos Dawndirector | Grant | 10,507 | $53.46 |
| Jun 3, 2026 | PATOU GARYdirector | Option | 2,645 | — |
| Jun 3, 2026 | GANNON STEVENdirector | Grant | 10,507 | $53.46 |
| Jun 3, 2026 | GANNON STEVENdirector | Tax | 1,416 | $53.41 |
| Jun 3, 2026 | GAROFALO ELIZABETH A.director | Option | 2,645 | — |
| Jun 3, 2026 | Svoronos Dawndirector | Grant | 1,593 | — |
| Jun 3, 2026 | GAROFALO ELIZABETH A.director | Grant | 1,593 | — |
| Jun 3, 2026 | PATOU GARYdirector | Grant | 1,593 | — |
| Jun 3, 2026 | Gover Justin D.director | Grant | 10,507 | $53.46 |
| Jun 3, 2026 | Cannon Gilliandirector | Option | 2,645 | — |
| Jun 3, 2026 | Cannon Gilliandirector | Grant | 10,507 | $53.46 |
| Jun 3, 2026 | Machado Patrickdirector | Option | 2,645 | — |
| Jun 3, 2026 | Machado Patrickdirector | Grant | 10,507 | $53.46 |
| Jun 3, 2026 | Gover Justin D.director | Option | 2,645 | — |
| Jun 3, 2026 | Gover Justin D.director | Grant | 1,593 | — |
| Jun 3, 2026 | Svoronos Dawndirector | Option | 2,645 | — |
| Jun 3, 2026 | PATOU GARYdirector | Grant | 10,507 | $53.46 |
| Jun 3, 2026 | GANNON STEVENdirector | Option | 2,645 | — |
| May 13, 2026 | GANNON STEVENdirector | Option | 3,500 | $7.38 |
| Mar 13, 2026 | DiFabio Andreaofficer: Chief Legal Officer | Option | 3,750 | — |
| Mar 13, 2026 | KENNEY CHRISTOPHER JOHNofficer: Chief Medical Officer | Option | 3,750 | — |
| Mar 13, 2026 | MORTIMER IANdirector, officer: PRESIDENT & CEO | Option | 12,500 | — |
| Mar 13, 2026 | MORTIMER IANdirector, officer: PRESIDENT & CEO | Sell | 7,308 | $55.23 |
| Mar 13, 2026 | DiFabio Andreaofficer: Chief Legal Officer | Sell | 1,342 | $55.23 |
| Mar 13, 2026 | KENNEY CHRISTOPHER JOHNofficer: Chief Medical Officer | Sell | 1,410 | $55.23 |
Source: XENE SEC Form 4 filings, latest Jun 3, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their XENE positions over the last 6 months (SEC Form 13F).
Increased
217
New positions
131
Reduced
135
Sold out
56
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| FMR LLC | Increased | 10.8M | May 15, 2026 |
| FMR LLC | Increased | 8.9M | Feb 17, 2026 |
| AVORO CAPITAL ADVISORS LLC | Increased | 5.8M | May 15, 2026 |
| BLACKROCK, INC. | Increased | 5.6M | May 13, 2026 |
| AVORO CAPITAL ADVISORS LLC | Increased | 5.4M | Mar 16, 2026 |
| BLACKROCK, INC. | Increased | 5.1M | Feb 12, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Increased | 4.8M | May 15, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Increased | 4.8M | Feb 17, 2026 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | Increased | 4.5M | Feb 17, 2026 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | Reduced | 4.5M | May 15, 2026 |
| POLAR CAPITAL HOLDINGS PLC | Increased | 4.4M | May 15, 2026 |
| JANUS HENDERSON GROUP PLC | Increased | 4.2M | May 18, 2026 |
| JANUS HENDERSON GROUP PLC | Increased | 4.1M | Feb 17, 2026 |
| CAPITAL INTERNATIONAL INVESTORS | Increased | 3.4M | Feb 11, 2026 |
| CAPITAL INTERNATIONAL INVESTORS | Reduced | 2.7M | May 13, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.